- Statement from FDA Commissioner Scott Gottlieb, M.D., on New Steps to Advance Agency’s Continued Evaluation of Potential Regulatory Pathways for Cannabis-Containing and Cannabis-Derived Products
- These Tech Companies Aim to Cure Pain Without Pills
- Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate Aimed at Fentanyl
- Mystery Opioid Overdose Device May Be a $1 Billion Opportunity
- FDA Rolls Out Vaping Policy to Make it Harder for Minors to Buy Flavored Products
- FDA’s Gottlieb to Resign Amid Opioid Crisis and Crackdown on Retail Youth Tobacco Sales
- Drug Companies Must Fund Opioid Studies to Curb Overdose Epidemic, Says FDA Commissioner
- FDA Plans Multifaceted Response to Opioid-Abuse Epidemic
- State College Medical Marijuana Dispensary Finds No Shortage of Customers